Published in Cochrane Database Syst Rev on January 21, 2009
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA (2009) 2.59
Treatment for mild cognitive impairment: systematic review. Br J Psychiatry (2013) 1.58
Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res (2012) 1.48
Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr (2011) 1.45
Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr (2010) 1.19
A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology (Berl) (2009) 1.18
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br J Clin Pharmacol (2013) 1.15
Ginkgo biloba in Alzheimer's disease: a systematic review. Wien Med Wochenschr (2010) 0.97
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research. J Neural Transm (Vienna) (2012) 0.97
Use of complementary and alternative medicine and self-rated health status: results from a national survey. J Gen Intern Med (2010) 0.96
Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging (2014) 0.95
Cochrane systematic reviews of Chinese herbal medicines: an overview. PLoS One (2011) 0.92
Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice. Int J Mol Sci (2010) 0.92
Current treatment and recent clinical research in Alzheimer's disease. Mt Sinai J Med (2010) 0.92
The role of inflammatory processes in Alzheimer's disease. Inflammopharmacology (2012) 0.92
Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol (2010) 0.89
Nutraceuticals in cognitive impairment and Alzheimer's disease. Front Pharmacol (2014) 0.87
Herbal therapy: a new pathway for the treatment of Alzheimer's disease. Alzheimers Res Ther (2010) 0.86
Assessment of health claims, content, and safety of herbal supplements containing Ginkgo biloba. Food Nutr Res (2010) 0.85
Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia. Chin Med (2011) 0.85
Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use. BMC Health Serv Res (2015) 0.84
Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial. Neurology (2012) 0.84
Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease. Curr Neuropharmacol (2013) 0.84
Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia. Acta Pharmacol Sin (2010) 0.83
Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. Am J Hypertens (2010) 0.83
A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine. Evid Based Complement Alternat Med (2013) 0.83
Ginkgo biloba extract for dementia: a systematic review. Shanghai Arch Psychiatry (2013) 0.81
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease. Int J Nanomedicine (2015) 0.81
The use of Ginkgo biloba in healthy elderly. Age (Dordr) (2013) 0.78
Mild cognitive impairment: The dilemma. Indian J Psychiatry (2009) 0.78
Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling. Drug Des Devel Ther (2015) 0.77
Neuroprotective effects of bilobalide are accompanied by a reduction of ischemia-induced glutamate release in vivo. Brain Res (2011) 0.77
Effect of ginkgo biloba on the pharmacokinetics of raltegravir in healthy volunteers. Antimicrob Agents Chemother (2012) 0.76
Role of complementary and alternative medicine in geriatric care: A mini review. Pharmacogn Rev (2014) 0.76
The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med (2016) 0.75
The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan. PLoS One (2015) 0.75
Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia. J Pharm Health Care Sci (2015) 0.75
Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial. Neuropsychiatr Dis Treat (2017) 0.75
Common dietary supplements for cognitive health. Aging health (2012) 0.75
Clinical trials with herbal medicinal products in children: a literature analysis. Wien Med Wochenschr (2015) 0.75
Direct and indirect risk associated with the use of dietary supplements among persons with dementia in a Norwegian memory clinic. BMC Complement Altern Med (2017) 0.75
Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev (2008) 1.52
Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev (2009) 1.24
N-of-1 randomized controlled trials ('N-of-1 trials'): singularly useful in geriatric medicine. Age Ageing (2002) 0.83
Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev (2015) 0.80
Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev (2015) 0.78
An N-of-1 randomized controlled trial ('N-of-1 trial') of donepezil in the treatment of non-progressive amnestic syndrome. Age Ageing (2002) 0.77